XML 30 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Capital Stock
3 Months Ended
Jun. 30, 2020
Stockholders' Equity Note [Abstract]  
Capital Stock

NOTE 12 – CAPITAL STOCK

 

During the three month period ended June 30, 2020, we issued 1,204,683 shares of common stock as follows:

 

  1,000,000 shares were sold to investors for $1,750,000
  60,607 shares were issued to investors for exercised warrants valued for $121,214
  279 shares were issued for cashless exercise of 1,967 warrants
  8,336 shares were issued for services provided to the Company value at $13,188
  180,916 shares valued at $255,300 were issued to employees, members of the Board of Directors, and members of the Advisory Committee as compensation

 

At June 30, 2020, we recorded a stock subscription receivable of $1,840,910 for 1,000,000 shares of Common Stock sold to an Investor for $1,750,000 or $1.75 per share and 45,455 shares issued to investors for exercised warrants at $2.00 per share for $90,910.

 

At June 30, 2020, outstanding and exercisable stock purchase warrants consisted of the following:

 

   

Number of

Shares

    Weighted Averaged
Exercise Price
   

Weighted

Average Life

Remaining
(Years)

 
Outstanding at March 31, 2020     8,504,372     $ 2.10       3.60  
Granted     -       -       -  
Exercised     (62,574 )     2.00       -  
Forfeited or cancelled     -       -       -  
Outstanding at June 30, 2020     8,441,798     $ 2.10       3.32  
Exercisable at June 30, 2020     8,441,798     $ 2.10       3.32  

 

As of June 30, 2020, we had 8,441,798 warrants outstanding. Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 966,494 shares of Common Stock at an exercise price of $1.65 per share until April 2025; (2) warrants to purchase 4,579,171 shares of our Common Stock at an exercise price of $2.00 per share over the next three to five years; and (3) warrants to purchase 2,896,133 shares of Common Stock at an exercise price of $2.40 over the next five years.